TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -0 | -2 | 8 | 13 | -19 | -53 | -9 |
| S | %wins | 33 | 67 | 67 | 67 | 67 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/16/08 16:34 | 6/12/08 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wyngaarden James B | NC | D | S | -19 | 14.50 | 1 | -1 | -3 | 37 | D | 307 | 98 | 29 | 50 | 2 | 0 | 5 | 8 | 1 | 1 | -6 | -7 | -46 | -53 | |
5/20/08 09:47 | 5/16/08 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wyngaarden James B | NC | D | S.d | -89 | 14.79 | 1 | -6 | -14 | 37 | D | 299 | 72 | 28 | 36 | 16 | 9 | 2 | 0 | 2 | -1 | -1 | -5 | -47 | -61 | |
3/17/08 14:27 | 3/13/08 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wyngaarden James B | NC | D | S.dm | -201 | 10.02 | 1 | -20 | -35 | 37 | D | 89 | 28 | 16 | -14 | -3 | -3 | -2 | 1 | -4 | -5 | 31 | 50 | 37 | -44 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |